Researchers From The Hartree Centre, IBM, And REPROCELL Propose An Explainable Machine Learning Approach That Combines Bioinformatics And Domain Insight To Inform Precision Medicine Strategies For Inflammatory Bowel Disease

A project supported by the STFC Hartree Centre Discovery Accelerator accurately predicts patient response to treatments for ulcerative colitis and Crohn’s disease.

Artificial intelligence may soon assist more than 6 million1 individuals worldwide who suffer from inflammatory bowel disease (IBD) in selecting the optimum medication for their illness. An explainable AI pharmacogenomics methodology we created effectively predicted how patients will respond — favorably or negatively — to an IBD treatment 95% of the time, according to research published in PLOSone. …

artificial bioinformatics disease explainable machine learning ibm insight learning machine machine learning medicine precision precision medicine researchers strategies